Effect of chronic treatment with naltrexone on hyperactive behavior in autistic children

Downloads

Published

1997-03-31

How to Cite

Gastaminza, X. (1997). Effect of chronic treatment with naltrexone on hyperactive behavior in autistic children. Revista De Psiquiatría Infanto-Juvenil, (1), 58–60. Retrieved from https://aepnya.eu/index.php/revistaaepnya/article/view/549

Issue

No. 1 (1997): January-March

Section

Book reviews

Authors

  • X. Gastaminza

Keywords:

autistic children

Abstract

Last September the 9th Congress of the European College of Neuropsychopharmacology took place in Amsterdam, thus providing a window with views of a beautiful city with the occasion of a panoramic view of the latest in psychopharmacology, where we will focus on pedopsychiatric psychopharmacology.

Downloads

Download data is not yet available.

References

Willemsen-Swirkels SHN, Buitelaar JK, Weijnenn FG, van Engelend H. Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatr Res 1995;58:2O3- 215. https://doi.org/10.1016/0165-1781(95)02749-M

Willemsen-Swirkels SHN, Buitelaar JK, van Engelend H. The effect of chronic naltrexone treatment on hyperactive behaviour in children with autism. Eur Neurosychofarmacol 1996;6(Supl 4):166. https://doi.org/10.1016/0924-977X(96)82921-X

Winsberg BG, Klee S, Pollack J. Effectiveness of pemoline among hyperkinetic children who fail to respond to methylphenidate. Eur Neuropsychopharmacol 1996;6(Supl 4): 166. https://doi.org/10.1016/0924-977X(96)83029-X

Amor M, Rodríguez Ramos P. Comorbilidad del trastorno obsesivo en niños y adolescentes. Análisis de estudios en población general y clínica. Rev Psiquiatría Infanto-Juvenil 1996;3:212-218.

Rodríguez-Ramos P. Asociación clomipramina-fluoxetina en adolescentes obsesivos refractarios a la monoterapia: nivel plas-mático y efectos clínicos. Rev Psiquiatría Infanto-Juvenil 1995;3:179-185.

Flament MF, Whitaker A, Papoport JL, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 1988;27:764-771. https://doi.org/10.1097/00004583-198811000-00018

Mundo E, Smeraldi E, Belloni L. Fluvoxamine in the treatment of obsessive-compulsive disorder: A double-blind comparison with clomipramine. Eur Neuropsychopharmacol 1996;6(Supl 4):139. https://doi.org/10.1016/0924-977X(96)82966-X

Ramunsen SA, Tsuang MT. The epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1984;45:450-457.

Baysal ZB, Ünal F. Fluoxetine treatment of children and adolescents with obsesive-compulsive disorders: A open-label trial. Eur Neuropsychopharmacol 1996;6(Supl 4):142-143. https://doi.org/10.1016/0924-977X(96)83139-7

Riddle MA, Claghorn J, Caffney G, et al. Fluvoxamine for children and adolescents with Obsessive Compulsive Disorder: A controlled multicenter trial. Eur Neuropsychopharmacol 1996;6(Supl 4): 144-145. https://doi.org/10.1016/0924-977X(96)82971-3

Wolkow R, Johnston AJ, et al. Sertraline treatment of children and adolescents with obsesive compulsive disorder or depression. Póster del 9° Congreso del European College of Neuropsycho-pharmacology. Amsterdam, 21-25 de septiembre de 1996.

Most read articles by the same author(s)

1 2 3 > >>